vaccin
effici
way
prevent
occurr
mani
infecti
diseas
human
date
sever
viral
vector
util
gener
vaccin
among
baculoviruscategor
nonhuman
viral
vectorha
use
wider
applic
versatil
featur
like
larg
clone
capac
nonrepl
natur
mammalian
cell
broad
tissu
tropism
hold
excel
posit
among
vaccin
vector
addit
eas
safeti
swift
product
recent
key
improv
exist
baculoviru
vector
inclus
hybrid
promot
immunostimulatori
element
etc
led
signific
improv
immunogen
efficaci
surfacedisplay
antigen
furthermor
promis
preclin
result
report
mirror
scope
practic
baculoviru
vaccin
vector
human
applic
near
futur
herein
review
provid
overview
induc
immun
respons
baculoviru
surfacedisplay
vaccin
influenza
infecti
diseas
anim
model
highlight
strategi
appli
enhanc
protect
immun
respons
display
antigen
exist
battl
human
immun
system
pathogen
longlast
histori
destin
continu
due
advanc
field
infecti
diseas
discoveri
effect
vaccin
therapi
recent
histori
aid
control
spread
diseas
howev
loom
danger
reemerg
pathogen
pose
seriou
issu
threaten
tilt
newfound
equilibrium
among
type
vaccin
avail
inactiv
vaccin
gener
consid
safe
stabl
given
inact
natur
vaccin
given
peopl
weaken
immun
system
without
seriou
complic
opportunist
infect
howev
immun
respons
induc
inactiv
vaccin
mainli
humor
repeat
immun
requir
improv
immun
target
diseas
moreov
inactiv
vaccin
may
retain
correct
antigen
conform
thu
induc
poor
immun
respons
target
antigen
contrast
live
attenu
vaccin
effect
induc
protect
immun
respons
vaccin
individu
major
risk
live
attenu
vaccin
possibl
revers
recombin
circul
strain
well
incompat
vaccin
immunocompromis
elderli
chronic
ill
pregnant
recombin
subunit
vaccin
hand
gener
use
regardless
health
statu
possess
disadvantag
disadvantag
includ
need
support
adjuv
improv
immunogen
purif
issu
due
hydrophob
natur
antigen
complic
purif
process
reduc
costeffect
vaccin
product
dna
vaccin
util
genet
engin
dna
capabl
induc
humor
cellmedi
immun
respons
parasit
bacteria
virus
modif
element
dna
promot
enhanc
enhanc
express
encod
protein
vaccin
recipi
moreov
mixtur
plasmid
encod
plethora
immunogen
gene
potenti
use
gener
broadspectrum
vaccin
howev
dna
vaccin
may
induc
antibodi
dna
result
autoimmun
respons
develop
immunolog
toler
recipi
host
sinc
viral
vaccin
vector
emerg
vector
favor
safeti
profil
live
attenu
viru
vaccin
better
immunogen
inactiv
vaccin
viral
vaccin
vector
present
desir
antigen
nativ
conform
result
stronger
immunogen
respons
maintain
higher
level
foreign
gene
express
vivo
compar
dna
vaccin
howev
consider
exist
use
viral
vector
vaccin
human
preexist
vector
immun
may
seriou
impact
vaccin
vector
efficaci
increas
transgen
size
could
caus
genet
instabl
decreas
viral
yield
overcom
issu
preexist
vector
immun
vaccin
vector
util
recombin
virus
nonhuman
origin
develop
avoid
neutral
viral
vector
preexist
antibodi
class
viru
infect
insect
cell
known
baculovirus
develop
use
nonhuman
viral
vector
among
variou
baculovirus
autographa
californica
multicapsid
nucleopolyhedroviru
acmnpv
wide
studi
acmnpv
larg
doublestrand
dna
viru
genom
size
kbp
contain
open
read
frame
orf
acmnpv
biphas
life
cycl
result
product
two
form
viru
bud
viru
bv
occlusionderiv
viru
odv
odv
respons
primari
infect
host
insect
bv
releas
host
cell
celltocel
infect
moreov
bv
produc
earli
stage
infect
wherea
odv
produc
late
stage
viral
infect
becom
concentr
nucleu
occlud
within
polyhedra
gener
acmnpv
express
gene
specif
time
phase
replic
cycl
gene
encod
protein
respons
viral
replic
andor
late
gene
express
eg
dnapol
express
earli
time
structur
protein
gene
eg
express
late
time
gene
express
earli
late
phase
eg
polyhedrin
polh
highli
express
late
late
time
infect
base
publish
report
acmnpv
promot
polyhedrin
polh
extens
use
express
foreign
protein
addit
convent
acmnpv
viral
promot
polh
show
high
level
recombin
protein
express
interestingli
combin
promot
exhibit
higher
level
protein
express
compar
standard
late
promot
alon
moreov
well
known
polyhedrin
promot
activ
late
stage
infect
bud
baculovirus
earli
stage
infect
unabl
effici
incorpor
target
protein
baculoviru
envelop
henc
use
immediateearli
promot
may
improv
incorpor
target
protein
viral
envelop
salient
featur
includ
eas
hightit
viru
product
capabl
simultan
deliveri
multipl
gene
potenti
transduct
abil
well
nonpathogen
nonrepl
natur
human
led
use
acmnpv
product
complex
eukaryot
protein
vitro
ex
vivo
vivo
also
vaccin
develop
use
surfac
display
technolog
review
describ
immun
respons
elicit
recombin
baculoviru
display
vaccin
variou
infecti
diseas
explor
uniqu
strategi
use
enhanc
protect
immun
baculoviru
display
antigen
tabl
ntnot
test
sinc
influenza
viru
consid
everpres
threat
human
caus
annual
epidem
infrequ
pandem
result
emerg
new
virul
strain
pose
sustain
alarm
public
health
emerg
current
best
method
prevent
control
influenza
viru
infect
via
vaccin
howev
tradit
influenza
viru
vaccin
effect
manag
infect
face
sever
challeng
limit
vaccin
product
capac
long
product
time
poor
growth
properti
select
vaccin
strain
necess
highlevel
biocontain
facil
major
issu
limit
vaccin
product
particularli
uncertainti
predict
emerg
pandem
viral
subtyp
pose
obstacl
prompt
product
vaccin
influenza
pandem
thu
novel
platform
rapid
develop
vaccin
overcom
limit
current
avail
tradit
vaccin
requir
swift
respons
influenza
outbreak
hemagglutinin
ha
major
surfac
glycoprotein
influenza
viru
main
target
gener
protect
immun
influenza
viru
known
key
determin
host
specif
introduct
new
ha
subtyp
found
associ
influenza
strain
respons
pandem
outbreak
henc
ha
could
serv
import
ideal
target
develop
influenza
vaccin
recombin
subunit
vaccin
present
one
method
target
ha
recombin
subunit
vaccin
target
ha
develop
use
insect
cell
express
system
extens
evalu
human
anim
influenza
vaccin
previous
trival
recombin
ha
influenza
vaccineflublok
produc
insect
cell
use
baculoviru
express
vectorwa
approv
us
fda
howev
need
high
dose
adjuv
vaccin
purif
issu
due
hydrophob
natur
ha
pose
major
setback
develop
recombin
subunit
vaccin
altern
strategi
vaccin
develop
use
baculoviru
surfac
display
techniqu
baculovir
vaccin
target
protein
express
surfac
viru
without
affect
replic
viru
moreov
insect
cell
possess
necessari
cellular
machineri
perform
extens
posttransl
modif
glycosyl
phosphoryl
disulfid
bond
format
essenti
express
mani
complex
eukaryot
protein
requir
modif
maintain
structur
integr
biolog
activ
furthermor
report
baculovirus
strong
adjuv
properti
capabl
induc
humor
cellular
immun
respons
vaccin
antigen
glycoprotein
major
envelop
protein
acmnpv
essenti
viral
infect
insect
cell
addit
domain
signal
sequenc
transmembran
cytoplasm
region
foreign
protein
glutathionestransferas
human
immunodefici
viru
hiv
protein
rubella
viru
envelop
protein
synthet
igg
bind
domain
display
baculovir
envelop
altern
certain
membran
protein
display
bud
viru
without
need
domain
exampl
vesicular
stomat
viru
vsvg
protein
measl
viru
receptor
independ
display
viral
envelop
similarli
ha
protein
incorpor
viral
envelop
without
domain
differ
region
signal
sequenc
transmembran
domain
cytoplasm
domain
wide
use
express
secretori
protein
baculovirusinsect
cell
express
system
exploit
display
foreign
protein
peptid
viral
envelop
case
studi
effici
incorpor
baculovir
envelop
shown
differ
recombin
baculovirus
carri
ha
differ
cytoplasm
domain
ctd
despit
equal
express
recombin
ha
express
histidinetag
ha
cytoplasm
domain
incorpor
ha
viral
envelop
effici
bacha
express
ha
hactd
cytoplasm
domain
ha
moreov
elicit
higher
hemagglutin
inhibit
titer
hi
compar
bacha
result
indic
import
cytoplasm
domain
degre
palmitoyl
domain
incorpor
ha
viral
envelop
vaccin
potenti
second
studi
modifi
vaccin
develop
employ
baculoviru
cytomegaloviru
cmv
promot
ha
demonstr
surfac
display
endogen
express
ha
transduct
immun
studi
vaccin
vector
system
reveal
superior
equival
immun
respons
ha
compar
vaccin
form
immun
respons
mediat
interact
antigenpres
cell
apc
via
major
histocompat
ii
mhcii
mediat
antigen
present
pathway
gener
vaccin
target
respiratori
viral
infect
like
influenza
act
induc
neutral
antibodi
neutral
virion
block
viral
attach
entri
host
cell
howev
current
avail
convent
vaccin
induc
humor
respons
homolog
strain
provid
inadequ
protect
heterolog
strain
contrast
tcellmedi
cellular
immun
respons
conserv
intern
region
antigen
mediat
protect
immun
heterolog
strain
previou
studi
stimul
helper
tlymphocyt
th
cell
cytotox
tlymphocyt
ctl
nucleoprotein
amino
acid
provid
complet
crossprotect
challeng
studi
sridhar
et
al
observ
individu
higher
number
preexist
tcell
conserv
epitop
show
milder
ill
infect
pandem
influenza
viru
furthermor
wilkinson
et
al
show
absenc
antibodi
respons
preexist
tcell
respond
influenza
intern
protein
reduc
sever
ill
demonstr
lower
shed
viru
recent
zhang
et
al
develop
recombin
baculovirusbas
vaccin
contain
three
tandem
copi
highli
conserv
extracellular
domain
influenza
protein
second
vaccin
addit
mucos
adjuv
heatliabl
enterotoxin
b
mice
inocul
vaccin
induc
higher
level
mucos
antibodi
effici
cellular
immun
differ
clade
clade
compar
nonadjuv
vaccin
interestingli
discov
mucos
immun
alon
insuffici
protect
lethal
challeng
wherea
adjuv
vaccin
provid
enhanc
protect
similar
challeng
tcell
respons
valid
role
tcell
enhanc
protect
immun
mice
deplet
tcell
inocul
mice
deplet
tcell
display
reduc
lung
viral
titer
signific
effect
surviv
rate
observ
compar
deplet
tcell
tcell
tcell
markedli
increas
lung
viral
titer
decreas
surviv
rate
research
enhanc
haspecif
immun
respons
util
baculoviru
vaccin
vector
addit
element
improv
immunogen
element
includ
cag
promot
mhc
class
signal
sequenc
mhciss
mhc
class
traffick
domain
mitd
woodchuck
hepat
viru
posttranscript
regulatori
element
wpre
cag
promot
enabl
robust
express
ha
mhciss
mitd
enhanc
mhc
class
ii
antigen
present
stimul
epitopespecif
tcell
wpre
hand
elev
ha
gene
express
increas
immunogen
shown
studi
mice
immun
baculoviru
possess
addit
element
induc
higher
level
haspecif
igg
higher
hemagglutin
inhibit
titer
better
tcell
respons
compar
baculovirus
without
addit
element
furthermor
role
wpre
itr
invert
termin
repeat
enhanc
ha
express
effect
induct
humor
cellular
immun
respons
studi
two
seri
baculoviru
use
differ
promot
drive
express
ha
gener
bv
seri
bvsha
bvsitrsha
bvsconha
util
cmv
promot
express
ha
bva
seri
bvaha
bvaitrsha
bvaconha
util
white
spot
syndrom
viru
wssv
immediateearli
promot
one
express
ha
result
immun
studi
indic
baculovir
vaccin
wssv
promot
induc
higher
level
humor
cellular
immun
compar
similar
baculovir
vaccin
util
cmv
promot
anoth
studi
recombin
baculoviru
vector
egfp
express
cassett
cmv
promot
examin
baculovir
vector
modifi
express
ha
use
baculoviru
polyhedrin
polh
promot
vacha
use
dualpromot
polh
cmv
promot
vachadu
ha
express
effici
insect
cell
construct
mice
vaccin
vacha
induc
higher
level
igg
iga
compar
mice
vaccin
vachadu
addit
stimul
splenocyt
immun
mice
haspecif
peptid
trigger
immun
respons
vachaimmun
mice
wherea
vachadualimmun
mice
show
immun
respons
moreov
vachadu
vaccin
effect
induc
haspecif
tcell
respons
vitro
report
signal
peptid
membran
protein
import
direct
protein
endoplasm
reticulum
membran
protein
traffick
transmembran
tm
domain
play
role
protein
traffick
membran
anchor
membran
fusion
viral
bud
wherea
ct
domain
crucial
envelop
incorpor
viru
bud
interact
compon
viral
core
incorpor
influenza
ha
baculoviru
envelop
support
observ
research
tang
et
al
function
role
signal
peptid
sp
ctd
region
tm
ha
incorpor
ha
baculoviru
envelop
studi
demonstr
enhanc
ha
incorpor
increas
hi
titer
baculoviru
sp
ctd
ha
tm
stark
contrast
recombin
baculovirus
contain
differ
combin
ha
domain
sp
hasp
hatm
hactd
hatm
hasp
ctd
sp
hasp
show
opposit
effect
ha
incorpor
hi
titer
base
result
second
gener
tetraval
baculovir
vaccin
develop
use
hatm
vaccin
display
four
subclad
influenza
virus
induc
strong
humor
cellular
immun
homolog
heterolog
strain
anoth
studi
effici
wssv
promotermedi
express
recombin
baculoviru
examin
also
confirm
express
baculoviru
abl
success
transloc
plasma
membran
infect
cell
observ
surfacedisplay
abl
sustain
antigen
conform
authent
cleavag
report
baculoviru
pseudotyp
vesicular
stomat
viru
glycoprotein
vsvg
vesicular
stomat
viru
vsv
effect
increas
transduct
level
mammalian
cell
capabl
increas
amount
express
protein
display
surfac
entir
viral
envelop
addit
recombin
baculoviru
display
ha
coexpress
vsvg
wssv
show
ha
display
baculoviru
surfac
high
ha
activ
intranas
intramuscular
immun
chicken
baculoviru
contain
wssv
induc
strong
haspecif
antibodi
hi
titer
compar
baculoviru
cmv
promot
nevertheless
coexpress
vsvg
virus
contribut
increas
antiha
antibodi
level
hi
activ
similarli
recombin
baculoviru
pseudotyp
vsvg
bvgha
shown
success
transduc
mammalian
cell
mediat
gene
deliveri
enabl
effici
express
immun
studi
reveal
vaccin
candid
induc
higher
level
antibodi
cellular
immun
compar
mice
vaccin
dna
vaccin
furthermor
immun
chicken
administ
vari
dose
demonstr
complet
protect
lethal
dose
highli
pathogen
avian
influenza
viru
howev
vaccin
effici
protect
mice
evolutionarili
distant
strain
possibl
due
high
degre
genet
diverg
influenza
viru
exampl
current
monoval
inactiv
whole
viru
vaccin
induc
neutral
antibodi
homolog
strain
show
lower
magnitud
respons
heterolog
strain
henc
necessari
develop
vaccin
express
antigen
cover
major
circul
virus
therefor
broaden
protect
efficaci
monoval
bvgha
vaccin
pseudotyp
baculovirusbas
bival
vaccin
encod
ha
clade
clade
influenza
virus
develop
mice
immun
pseudotyp
baculovirusbas
bival
vaccin
induc
significantli
higher
humor
cellular
immun
respons
provid
complet
protect
virus
clade
clade
compar
candid
use
studi
similarli
crossprotect
efficaci
wssv
promotercontrol
bival
baculoviru
surfacedisplay
ha
bivalentbacha
test
anoth
studi
mice
oral
vaccin
use
live
bivalentbacha
vaccin
show
system
mucos
immun
unlik
mice
immun
subcutan
live
inactiv
bival
vaccin
induc
robust
system
immun
level
system
immun
induc
oral
bival
vaccin
immun
mice
lower
compar
subcutan
immun
howev
mice
oral
immun
bivalentbacha
vaccin
demonstr
strong
haspecif
mucos
iga
respons
addit
oral
vaccin
induc
potent
crossclad
neutral
antibodi
distinct
clade
virus
absent
monoval
inact
whole
vaccin
wherea
mice
subcutan
vaccin
live
inactiv
bivalentbacha
vaccin
show
low
neutral
titer
clade
compar
clade
virus
enzymelink
immunospot
assay
reveal
mice
immun
oral
subcutan
live
bival
vaccin
trigger
cell
cell
mice
immun
subcutan
inact
adjuv
bival
vaccin
stimul
respons
moreov
mice
vaccin
oral
subcutan
live
bival
bacha
vaccin
show
complet
crossprotect
clade
clade
virus
suggest
bival
vaccin
potenti
protect
crossclad
virus
pandem
situat
sinc
baculoviru
prove
effici
express
foreign
gene
capabl
transduct
varieti
cell
line
research
util
viru
potenti
vaccin
vector
variou
infecti
agent
furthermor
addit
element
like
vsvg
protein
includ
research
increas
effici
transduct
gene
deliveri
express
recipi
host
recombin
baculovir
vector
express
vsvg
influenza
ha
shown
evok
humor
cellular
immun
respons
provid
effect
protect
lethal
viru
challeng
mous
chicken
host
high
cytotox
vsvg
protein
immedi
inactiv
serum
complement
system
imped
use
element
vaccin
deliveri
vehicl
recent
report
shown
human
endogen
retroviru
herv
envelopeco
recombin
baculovirusbas
human
papillomaviru
vaccin
significantli
improv
express
mammalian
cell
induc
humor
immun
respons
compar
level
obtain
use
commerci
cervic
cancer
viruslik
particl
vaccin
report
herv
envelopeco
baculovirusbas
ha
pandem
influenza
vaccin
induc
strong
cellular
immun
respons
compar
commerci
vaccin
anoth
studi
prabakaran
et
al
develop
recombin
baculoviru
display
ha
vaccin
control
wssv
promot
bacha
pandem
viru
vaccin
show
success
ha
express
envelop
mice
vaccin
studi
show
live
adjuv
inact
form
recombin
baculoviru
induc
haspecif
antibodi
respons
offer
complet
protect
lethal
viral
infect
studi
shown
high
neutral
antibodi
gener
influenza
viru
target
specif
region
globular
head
influenza
ha
moreov
ha
stalk
domain
well
conserv
antibodi
target
region
capabl
neutral
heterolog
influenza
viral
subtyp
exampl
chimer
ha
construct
express
globular
head
stalk
region
differ
subtyp
induc
antibodi
show
broad
protect
similarli
mice
immun
recombin
baculoviru
display
ha
pandem
influenza
viru
induc
hastalkspecif
antibodi
demonstr
protect
immun
homolog
heterolog
subtyp
virus
recent
decad
avian
influenza
viru
respons
numer
influenza
outbreak
among
poultri
industri
europ
north
america
sinc
none
poultryadapt
virus
evolv
wide
infect
human
caus
pandem
howev
case
viru
acquir
abil
infect
mammal
evidenc
largest
outbreak
highli
pathogen
poultri
industri
netherland
human
infect
report
virus
isol
patient
shown
possess
replic
potenti
human
conjunctiva
abil
humantohuman
transmiss
interestingli
virul
viru
chicken
turkey
increas
acquisit
addit
amino
acid
hemagglutinin
ha
cleavag
site
human
infect
avian
influenza
subtyp
first
report
china
caus
sever
wave
human
infect
specul
viru
possess
high
mutagen
contribut
abil
infect
human
higher
mutagen
may
caus
enhanc
pathogen
support
recent
human
case
isol
viru
found
mutat
associ
reduc
suscept
neuraminidas
inhibitor
use
antivir
treatment
sinc
subtyp
virus
pose
major
challeng
public
health
poultri
industri
numer
vaccin
gener
subtyp
virus
use
variou
platform
recent
baculoviru
display
ha
vaccin
develop
efficaci
test
via
intranas
subcutan
sc
administr
mice
observ
intranas
immun
mice
live
baculoviru
display
ha
vaccin
induc
higher
compar
humor
mucos
cellular
immun
respons
compar
vaccin
candid
irrespect
immun
rout
addit
immun
provid
complet
protect
wherea
protect
observ
mice
vaccin
vaccin
candid
anoth
studi
recombin
baculovirusbas
vaccin
bacha
avian
viru
high
pandem
potenti
gener
immunogen
crossprotect
efficaci
evalu
mice
found
live
bacha
immun
mice
elicit
high
level
haspecif
iga
mucos
immun
respons
humor
immun
respons
compar
mice
administ
subcutan
live
bacha
hand
subcutan
immun
adjuv
inact
bacha
stimul
robust
humor
immun
respons
induc
higher
neutral
antibodi
virus
subtyp
virus
compar
vaccin
candid
addit
subcutan
immun
inact
whole
vaccin
protect
challeng
demonstr
insuffici
protect
subtyp
wherea
mice
vaccin
subcutan
live
inact
recombin
baculoviru
protect
mice
challeng
furthermor
mice
immun
live
bacha
show
complet
protect
infect
challeng
studi
report
differ
immunogen
ha
ha
might
due
amino
acid
chang
introduc
potenti
glycosyl
site
posit
mask
epitop
account
differ
immunogen
kumar
et
al
compar
ha
virus
select
three
posit
studi
b
c
locat
within
near
receptorbind
site
ha
protein
sitedirect
mutagenesi
gener
six
mutant
construct
singl
doubl
amino
acid
substitut
three
posit
among
gener
mutant
construct
bacha
mice
vaccin
construct
induc
higher
hemagglutin
inhibit
neutral
titer
neutral
virus
compar
mice
immun
bacha
mutant
vaccin
result
show
substitut
amino
acid
respons
form
potenti
glycan
motifepitop
mask
would
improv
immunogen
vaccin
candid
anoth
studi
mice
immun
baculovirusdisplay
ha
low
pathogen
influenza
subtyp
trigger
higher
haspecif
humor
mucos
cellular
immun
compar
mice
immun
inactiv
influenza
viru
moreov
regardless
immun
rout
confer
protect
lethal
homolog
mouseadapt
viru
moreov
recombin
baculoviru
cmvpolyhedrin
dual
promot
express
chimer
ha
shown
effici
express
ha
mammalian
insect
cell
induc
strong
immun
respons
provid
protect
lethal
viral
challeng
mice
unlik
vaccin
candid
observ
shrimp
immun
reli
innat
immun
mechan
lack
adapt
immun
hinder
vaccin
develop
shrimp
pathogen
though
limit
exist
develop
shrimp
vaccin
presenc
quasiimmun
respons
natur
experiment
infect
white
spot
syndrom
viru
wssv
p
japonica
resist
experiment
rechalleng
wssv
due
neutral
factor
survivor
plasma
encourag
research
continu
develop
vaccin
wssv
viru
sever
attempt
made
develop
vaccin
target
immunogen
protein
wssv
viru
sy
musthaq
et
al
develop
recombinantbas
vaccin
display
recombin
envelop
confoc
transmiss
electron
microscopi
analysi
confirm
abl
local
plasma
membran
infect
insect
cell
viru
also
success
acquir
envelop
insect
cell
membran
bud
process
approxim
protein
anchor
envelop
viral
particl
furthermor
protect
efficaci
wssv
infect
test
via
inject
oral
immers
method
shrimp
shrimp
success
transcrib
translat
show
surviv
rate
wssv
viru
challeng
day
postvaccin
respect
hand
transcript
level
lipopolysaccharid
bind
protein
lgbp
signal
transduc
activ
transcript
stat
gene
crucial
trigger
innat
immun
respons
alter
differ
day
postinfect
dpi
shrimp
vaccin
oral
immers
rout
express
level
stat
gene
control
group
downregul
variou
dpi
wssv
infect
progress
vaccin
group
stat
gene
level
decreas
dpi
start
increas
dpi
dpi
moreov
level
lgbp
gene
control
group
upregul
infect
progress
wherea
vaccin
group
show
increas
level
earli
infect
later
decreas
wssv
infect
clear
result
confirm
oral
vaccin
trigger
innat
immun
respons
possibl
respons
higher
surviv
rate
upon
wssv
challeng
day
postvaccin
also
shrimp
vaccin
immers
vaccin
show
surviv
rate
compar
mortal
obtain
control
group
challeng
studi
porcin
reproduct
respiratori
syndrom
viru
prrsv
classic
swine
fever
viru
csfv
porcin
circoviru
type
major
pathogen
continu
affect
pig
industri
caus
signific
econom
loss
worldwid
date
research
world
contribut
variou
form
vaccin
util
differ
strategi
target
pathogen
virusbas
vector
vaccin
develop
use
modifi
vaccinia
viru
ankara
canin
pseudorabi
viru
semliki
forest
viru
howev
vector
mammalian
origin
pose
biohazard
threat
contrast
recombin
baculovirus
possess
good
safeti
profil
util
develop
vaccin
prrsv
csfv
virus
use
sp
tm
ct
domain
xu
et
al
develop
recombin
baculovirusbas
bival
vaccin
vector
surfacedisplay
major
immunogen
induc
neutral
antibodi
prrsv
infect
major
immunogen
capsid
cap
protein
swine
vaccin
studi
demonstr
vaccin
candid
stimul
potent
capspecif
neutral
antibodi
induc
higher
lymphocyt
prolifer
respons
compar
control
group
indic
bival
vaccin
potenti
use
vaccin
mix
prrsv
infect
anoth
studi
orf
prrsv
success
display
baculoviru
envelop
use
sp
tm
ctd
region
antibodi
respons
elicit
vector
vaccin
sustain
day
booster
wherea
titer
inactiv
prrsvvaccin
group
reduc
dramat
time
point
enhanc
immun
respons
could
due
vivo
transduct
prrsv
gene
baculoviru
vaccin
activ
endogen
antigenprocess
present
pathway
amongst
vaccin
develop
studi
baculovirus
display
induc
higher
antibodi
respons
mice
compar
vaccin
candid
recombin
baculovirusbas
vaccin
contain
cap
vsvg
protein
develop
express
place
control
cmv
polh
promot
wherea
express
vsvg
place
promot
due
vsvgmediat
transduct
success
express
cap
protein
transduc
cell
behav
subunitdna
vaccin
induc
robust
cap
proteinspecif
humor
cellular
immun
respons
studi
report
e
rn
glycoprotein
main
immunogen
protein
csfv
induc
neutral
antibodi
provid
protect
immun
csfv
xu
et
al
gener
recombin
baculovirus
surfacedisplay
either
e
rn
bacsc
rn
fusion
form
domain
presenc
domain
alter
viral
titer
recombin
virus
moreov
mice
vaccin
studi
reveal
bacsc
rn
induc
stronger
e
rn
specif
antibodi
respect
compar
vaccin
candid
suggest
vaccin
candid
could
potenti
appli
treatment
csfv
infect
respiratori
syncyti
viru
rsv
common
contagi
viru
caus
acut
lower
respiratori
tract
infect
infant
young
children
elderli
immunocompromis
individu
current
approv
vaccin
avail
treat
infect
human
studi
report
immun
recombin
viral
vector
express
rsvg
protein
show
immun
patholog
issu
enhanc
skew
tcell
respons
counter
issu
zhang
et
al
develop
recombin
baculoviru
vaccin
show
reduc
immun
patholog
condit
mice
four
vaccin
construct
develop
display
f
ectodomain
tf
envelop
baccf
express
fulllength
f
protein
transduc
mammalian
cell
display
tf
envelop
express
f
cell
contain
addit
virusinduc
signal
adaptor
visa
gene
baccf
show
increas
mix
cytokin
respons
higher
level
antibodi
respons
reduc
immunopatholog
upon
rsv
challeng
compar
moreov
coexpress
visa
reduc
immun
respons
induc
protect
lung
inflammatori
immun
respons
upon
subsequ
rsv
challeng
therefor
inclus
visa
element
could
effect
altern
vaccin
strategi
rsv
infect
rabi
viru
rabv
highli
infecti
pose
constant
threat
human
anim
tradit
vaccin
develop
rabv
mainli
focus
induc
neutral
antibodi
howev
studi
shown
addit
humor
immun
cellular
immun
respons
import
provid
protect
immun
rabv
previous
recombin
baculoviru
viral
vector
vaccin
rabv
glycoprotein
rvg
construct
bvrvgrvg
vector
express
two
type
rvg
antigen
baculovirusexpress
rvg
vivo
express
rvg
enhanc
specif
immun
respons
rvg
antigen
base
immun
studi
bvrvgrvgimmun
mice
display
higher
humor
cellular
immun
respons
offer
complet
protect
rabv
compar
mice
immun
vaccin
candid
enhanc
immunogen
could
due
immedi
recognit
rvg
incorpor
bvrvgrvg
immunocompet
cell
result
present
dendrit
cell
dc
subsequ
activ
b
cell
secret
viralspecif
neutral
antibodi
furthermor
cmvmediat
vivo
rvg
express
bvrvgrvg
activ
endogen
antigen
present
pathway
induc
persist
specif
immun
respons
anoth
studi
feng
et
al
display
entir
ectodomain
sarscov
spike
protein
baculoviru
envelop
use
signal
peptid
vsvg
membran
anchor
mice
vaccin
induc
specif
neutral
antibodi
protein
absenc
adjuv
subsequ
studi
research
develop
recombin
baculoviru
vaccin
avian
infecti
bronchiti
viru
ibv
japanes
enceph
viru
jev
bovin
domain
sp
tm
ctd
chicken
immun
baculoviru
display
protein
ibv
vaccin
induc
humor
cellular
immun
respons
show
better
protect
compar
vaccin
studi
hand
glycoprotein
e
jev
display
baculoviru
envelop
induc
strong
neutral
antibodi
mice
swine
offer
protect
vaccin
mice
lethal
jev
challeng
similarli
envelop
glycoprotein
gd
display
baculoviru
envelop
elicit
strong
neutral
antibodi
mice
enteroviru
immunogen
capsid
protein
nonmembran
protein
requir
addit
region
like
sp
tm
ctd
ha
domain
success
incorpor
envelop
membran
protein
like
ha
na
neuraminidas
transloc
plasma
membran
incorpor
onto
envelop
viral
bud
meng
et
al
gener
recombin
baculovirus
wssv
polyhedrin
promot
surfacedisplay
chimer
fuse
sp
matur
domain
transmiss
electron
microscopi
analysi
confirm
success
anchor
recombin
baculovir
envelop
mice
found
induc
slightli
higher
antibodi
potent
neutral
activ
neutral
subgenogroup
heterolog
subgenogroup
show
neutral
activ
compar
inactiv
vaccin
subsequ
premanand
et
al
gener
recombin
baculoviru
surfacedisplay
chimer
use
minim
fusion
partner
like
sp
aa
transmembran
domain
aa
ctd
aa
facilit
better
incorpor
higher
baculoviru
titer
expectedli
contain
higher
envelop
compar
envelop
mice
elicit
stronger
antibodi
respons
crossneutr
activ
homolog
heterolog
strain
compar
vaccin
moreov
provid
protect
mouseadapt
lethal
strain
studi
mention
anchor
viral
envelop
similar
type
transmembran
protein
unrestrict
nterminu
exposur
mimick
type
transmembran
protein
kolp
et
al
gener
recombin
baculoviru
surfacedisplay
use
influenza
neuraminidas
na
result
type
ii
transmembraneanchor
pattern
distal
cterminu
mice
immun
studi
reveal
induc
humor
cellular
immun
respons
provid
protect
suckl
balbc
mice
mouseadapt
strain
challeng
infecti
bursal
diseas
viru
ibdv
caus
agent
infecti
bursal
diseas
affect
chicken
caus
consider
econom
loss
poultri
industri
report
live
attenu
vaccin
elicit
lower
level
antibodi
fail
protect
chicken
ibdv
target
issu
xu
et
al
gener
recombin
baculoviru
surfacedisplay
protein
use
tm
ct
domain
chicken
demonstr
higher
level
neutral
antibodi
better
protect
immun
virul
ibdv
strain
control
group
furthermor
ibdvspecif
lymphocyt
observ
chicken
also
major
immunogen
capsid
protein
canin
parvoviru
type
immunogen
protein
avian
reoviru
arv
util
develop
baculovirusbas
vaccin
arv
respect
fusion
domain
sp
tm
ctd
capsid
protein
allow
incorpor
baculovir
envelop
anim
vaccin
studi
reveal
baculoviru
surfac
display
induc
higher
neutral
antibodi
mice
compar
vaccin
test
moreov
recombin
baculovirus
display
immunogen
protein
either
arv
elicit
strong
antibodi
titer
higher
neutral
activ
compar
antibodi
respons
vaccin
candid
malaria
global
diseas
caus
plasmodium
parasit
endem
tropic
subtrop
region
result
million
death
annual
recombin
proteinbas
subunit
vaccin
contain
part
major
surfac
protein
plasmodium
falciparum
circumsporozoit
protein
pfcsp
provid
shortliv
protect
immun
effect
period
affect
age
group
malaria
transmiss
intens
anoth
vaccin
plasmodium
falciparum
sporozoit
pfspz
report
provid
protect
homolog
heterolog
human
malaria
infect
aim
curb
spread
malaria
set
goal
vaccin
effici
year
novel
altern
strategi
requir
ensur
develop
effect
vaccin
malaria
infect
develop
vaccin
dual
function
malaria
vaccin
act
liverdirect
gene
deliveri
vehicl
yoshida
et
al
develop
recombin
baculovirusbas
vaccin
display
rodent
malaria
parasit
plasmodium
berghei
circumsporozoit
protein
pbcsp
immun
studi
vaccin
induc
humor
cellular
immun
responsea
provid
protect
sporozoit
challeng
subsequ
seri
baculovirusbas
vaccin
express
pfcsp
delet
glycosylphosphatidylinositol
gpi
anchor
region
control
polh
cmv
promot
develop
acnpvc
vector
express
cs
protein
apc
control
cmv
promot
enabl
preferenti
induct
tcell
upon
mhc
class
present
vector
express
cs
protein
fusion
form
use
polyhedrin
promot
insect
cell
allow
incorpor
cs
baculoviru
envelop
bud
process
mimick
p
falciparum
sporozoit
uptak
apc
trigger
cell
via
mhc
class
ii
present
induc
potent
humor
immun
respons
combin
express
present
recombin
cs
antigen
mammalian
cell
induc
csspecif
tcell
mous
vaccin
studi
show
vaccin
induc
effici
humor
cellular
immun
respons
intramuscular
immun
compar
vaccin
candid
recombin
baculoviru
dual
expressionbas
malaria
vaccin
drive
pbcsp
express
polh
cmv
promot
develop
mice
immun
vaccin
induc
respons
intramuscular
inocul
provid
complet
protect
sporozoit
challeng
anoth
baculovirusbas
vaccin
candid
display
major
surfac
antigen
p
falciparum
develop
transmissionblock
vaccin
human
malaria
im
immun
mice
show
high
level
antibodi
effect
transmissionblock
respons
intranas
intramuscular
reduct
oocyst
intens
anoth
case
studi
recombin
baculovirusbas
plasmodium
vivax
transmissionblock
vaccin
use
autographa
california
nuclear
polyhedrosi
viru
develop
display
acnpv
envelop
nativ
conform
also
express
upon
transduct
mammalian
cell
induc
antibodi
intranas
intramuscularli
immun
mice
moreov
rabbit
immun
studi
vaccin
induc
signific
transmissionblock
respons
regardless
immun
rout
subcutan
intramuscular
intranas
yoshida
et
al
develop
baculovirusbas
nasal
drop
vaccin
surfacedisplay
carboxyl
terminu
merozoit
surfac
protein
plasmodium
yoelii
intranas
intramuscular
immun
mice
induc
mix
immun
respons
provid
protect
efficaci
howev
intranas
immun
elicit
higher
specif
antibodi
titer
stronger
natur
boost
challeng
studi
anoth
studi
baculoviru
dualexpress
systembas
pfcsp
protein
bdespfcsp
vaccin
gener
base
immun
studi
vaccin
found
induc
mix
immun
respons
mice
gener
higher
level
pfcspspecif
antibodi
confer
signific
protect
malaria
addit
sera
immun
monkey
prevent
sporozoit
invas
cell
multistag
malaria
vaccin
develop
use
baculoviru
platform
target
inhibit
plasmodium
parasit
preerythrocyt
sexual
stage
gener
baculoviru
display
correct
fold
p
vivax
circumsporozoit
protein
pvcsp
protein
fusion
form
act
preerythrocyt
transmissionblock
activ
vaccin
vaccin
induc
higher
antibodi
level
pvcsp
provid
protect
malaria
transmissionblock
activ
recent
studi
human
decayacceler
factor
hdaf
incorpor
baculoviru
vector
effect
display
hdaf
pfcsp
surfac
baculovir
envelop
prevent
serum
complement
inactiv
follow
intramuscular
immun
modifi
vaccin
confer
higher
protect
efficaci
compar
control
group
challeng
studi
mucos
surfac
respiratori
gastrointestin
urogenit
tract
provid
major
rout
entri
variou
microorgan
mucos
immun
system
act
first
line
defens
microbi
infect
therefor
trigger
mucos
immun
system
import
prevent
infect
achiev
mucos
vaccin
via
intranas
oral
pulmonari
rectal
vagin
rout
administr
among
rout
oral
intranas
immun
two
viabl
option
vaccin
deliveri
nasal
rout
particular
offer
sever
advantag
like
possibl
selfadministr
induct
mucos
system
immun
gastric
mucosa
respiratori
tract
genit
tract
well
lower
dose
antigen
adjuv
requir
compar
oral
vaccin
sever
nonhuman
viral
vector
develop
recent
year
among
baculovir
vector
baculoviru
report
possess
strong
adjuv
properti
mammal
promot
enhanc
humor
mucos
cellular
immun
respons
coadminist
antigen
support
previou
report
indic
mice
immun
baculoviru
genom
dna
ovalbumin
show
humor
cytotox
tlymphocyt
respons
coadminist
antigen
abund
cpg
motif
baculoviru
improv
abil
induc
innat
immun
respons
endosom
recognit
pathway
dnadepend
activ
interferon
regulatori
factormedi
pathway
studi
shown
intranas
inocul
mice
wildtyp
baculoviru
provid
protect
influenza
b
strain
highlight
potenti
baculovir
vector
develop
vaccin
mucos
acquir
pathogen
intranas
immun
mice
live
recombin
baculoviru
bacha
vaccin
induc
significantli
higher
mucos
iga
immun
respons
compar
intranas
deliv
vaccin
higher
immun
respons
could
attribut
effici
transduct
baculovir
vector
strong
adjuv
properti
baculoviru
due
presenc
unmethyl
cpg
motif
addit
deliveri
bacha
stimul
higher
amount
compar
sc
immun
live
bacha
similarli
report
studi
enhanc
cytokin
level
could
due
recal
respons
splenocyt
due
presenc
nasopharynxassoci
lymphoid
follicl
nasal
mucosa
trigger
antigenspecif
th
lymphocyt
ctl
iga
immun
respons
challeng
studi
mice
reveal
immun
mice
live
bacha
show
protect
lethal
viral
challeng
compar
vaccin
irrespect
rout
administr
even
though
sc
immun
mice
achiev
higher
level
igg
antibodi
incap
bacha
protect
lethal
viral
challeng
could
due
lack
mucos
iga
crucial
clear
upper
respiratori
tract
infect
igg
anoth
studi
recombin
baculovirusbas
vaccin
anoth
pandem
potenti
avian
viru
gener
bacha
found
mice
intranas
immun
live
bacha
elicit
higher
level
haspecif
mucos
humor
immun
respons
mice
vaccin
subcutan
live
inact
baculoviru
display
ha
protect
mice
challeng
mice
immun
intranas
live
bacha
show
complet
protect
infect
challeng
studi
result
indic
import
addit
mucos
immun
recoveri
protect
subtyp
infect
inclus
adjuv
improv
immun
respons
induc
vaccin
caus
better
immun
respons
mucos
adjuv
particular
due
induct
protect
local
system
immun
respons
variou
infecti
diseas
also
intranas
immun
recombin
baculovirusdisplay
ha
viru
induc
high
level
mucos
iga
serum
igg
immun
respons
mice
combin
recombin
mucos
adjuv
ctb
enhanc
serum
igg
iga
respons
compar
unadjuv
log
log
ha
titer
bacha
alon
log
ha
titer
live
bacha
rctb
confer
protect
homolog
heterolog
strain
suggest
combin
safe
adjuv
vaccin
would
ideal
optim
efficaci
intranas
vaccin
oral
administr
consid
anoth
effici
rout
deliv
mucos
vaccin
noninvas
safe
show
good
patient
complianc
exampl
oral
polio
vaccin
highli
contagi
polioviru
help
erad
polioviru
infect
part
world
moreov
studi
shown
oral
vaccin
prevent
infect
lung
capabl
induc
mucos
immun
respons
iga
respiratori
tract
provid
protect
influenza
virus
prabakaran
et
al
report
live
recombin
baculoviru
display
ha
viru
bacha
abl
express
ha
epitheli
cell
intestin
oral
vaccin
mice
induc
strong
system
mucos
immun
respons
mice
immun
live
bacha
without
inclus
adjuv
confer
protect
homolog
heterolog
strain
immun
inactiv
bacha
result
lower
surviv
rate
reduc
immun
respons
inactiv
bacha
could
due
loss
transduct
abil
wherea
live
bacha
abl
bind
receptor
express
intestin
cell
result
gene
deliveri
stimul
cellmedi
immun
respons
moreov
formul
inactiv
vaccin
huge
impact
immunogen
one
studi
immunogen
lost
inactiv
baculoviru
display
ha
bacha
vaccin
recov
encapsul
use
revers
micel
phosphatidylcholin
adjuv
mice
oral
immun
encapsul
inact
bacha
induc
system
mucos
immun
respons
compar
live
bacha
howev
limit
use
mucos
adjuv
human
asid
effect
adjuv
major
concern
use
mucos
adjuv
possibl
detriment
impact
human
therefor
adjuv
use
mucos
immun
proven
safe
use
premanand
et
al
util
natur
occur
lipidbas
vesicl
bilosom
mucos
adjuv
coat
recombin
baculoviru
oral
immun
studi
reveal
associ
bilosom
induc
higher
immun
respons
confer
complet
protect
challeng
studi
overcom
hurdl
select
safe
mucos
adjuv
data
analysi
appli
search
suitabl
mucos
adjuv
understand
mechan
action
addit
new
technolog
novel
concept
welcom
develop
suitabl
mucos
adjuv
final
consider
deliveri
rout
appropri
combin
vaccin
adjuv
essenti
ensur
optim
effect
vaccin
human
baculoviru
surfacedisplay
vaccin
proven
effect
induc
protect
immun
respons
anim
model
howev
advanc
context
immunogen
made
util
hybrid
promot
enhanc
express
anchor
complex
protein
recombin
baculovir
envelop
addit
inclus
novel
regulatori
element
molecular
adjuv
propertycarri
motif
vector
certainli
boost
immunogen
antigen
display
baculoviru
envelop
main
obstacl
implement
baculoviru
surfacedisplay
vaccin
human
vaccin
candid
lack
safeti
guidelin
human
immun
howev
intern
organ
like
organ
econom
cooper
develop
directorategener
conclud
advers
effect
baculoviru
human
health
observ
safeti
test
pathogen
carcinogen
genotox
mammalian
cell
howev
environment
ecolog
impact
baculoviru
invertebr
reduc
modif
baculoviru
essenti
gene
requir
replic
bud
allow
develop
baculoviru
surfacedisplay
vaccin
optim
safeti
profil
futur
fund
research
receiv
extern
fund
